logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
4/17/2018 8:31:27 AM Merck Begins Two Phase 3 Studies Of PCV-15 (V114) For Prevention Of Pneumococcal Disease
4/16/2018 9:31:25 AM Merck’ KEYTRUDA Plus Pemetrexed And Platinum Chemotherapy Reduced Risk Of Death By Half Compared With Chemotherapy Alone
4/15/2018 11:47:58 AM Merck Announces Findings From Phase 3 EORTC1325/KEYNOTE-054 Trial Investigating KEYTRUDA
4/9/2018 6:46:19 AM Merck Says KEYTRUDA Monotherapy Meeta Primary Endpoint In Phase 3 KEYNOTE-042 Study
4/9/2018 1:20:14 AM New Drugs Approved In March
4/6/2018 7:31:46 AM Incyte And Merck Provide Update On Phase 3 Study Of Epacadostat In Combination With KEYTRUDA
4/3/2018 6:03:53 AM Merck: EMA Accepts Regulatory Submission For LYNPARZA In BRCA-Mutated HER2-Negative Metastatic Breast Cancer